Ikegami, Toru <br/><br/>
Rituximab, IVIG, and plasma exchange without graft local infusion treatment: a new protocol in ABO incompatible living donor liver transplantation.  [electronic resource] 

 -  Transplantation  Aug 2009 
 - 303-7 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1534-6080 
<br/><br/><label>Standard No.: </label>10.1097/TP.0b013e3181adcae6  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>ABO Blood-Group System<br/>Adult<br/>Agglutination--drug effects<br/>Antibodies, Monoclonal--therapeutic use<br/>Antibodies, Monoclonal, Murine-Derived<br/>Antigens, CD20--blood<br/>Blood Group Incompatibility<br/>Blood Grouping and Crossmatching<br/>Catheterization, Peripheral--adverse effects<br/>Combined Modality Therapy<br/>Female<br/>Graft Rejection--blood<br/>Graft Survival--drug effects<br/>Hepatic Artery<br/>Humans<br/>Immunoglobulins, Intravenous--therapeutic use<br/>Immunosuppressive Agents--therapeutic use<br/>Liver Cirrhosis--blood<br/>Liver Transplantation<br/>Living Donors<br/>Male<br/>Middle Aged<br/>Pilot Projects<br/>Plasma Exchange<br/>Portal Vein<br/>Rituximab<br/>Splenectomy<br/>Time Factors<br/>Treatment Outcome<br/>Young Adult